 Cost effectiveness incremental programmes serum cholesterol concentration individual intervention worth OBJECTIVE relative cost effectiveness various cholesterol programmes DESIGN Retrospective analysis SETTING Norwegian cholesterol programme Norwegian male population interventions population promotion healthier habits dietary treatment subjects serum cholesterol concentration mmol/l dietary drug treatment serum cholesterol concentration equal mmol/l MAIN OUTCOME MEASURE Marginal cost effectiveness ratios ratio net treatment costs cost treatment minus savings treatment costs coronary heart disease life years quality life years QALYs RESULTS cost life year years population strategy pounds individual strategy dietary treatment cost pounds life year pounds drugs subjects serum cholesterol concentrations equal mmol/l CONCLUSIONS results importance marginal cost effectiveness analyses incremental programmes health care calculations QALYs speculative individual intervention selected groups Drugs subjects genetic hypercholesterolaemia high risk arteriosclerotic disease